Skip to main content
. 2021 Feb 19;118(7):109–115. doi: 10.3238/arztebl.m2021.0014

Table 1. Selected meta-analytical effect sizes of MI in medical settings for different target criteria according to Lundahl et al. (14).

Target behavior/outcomes Number of studies OR [95% Confidence interval]*1 Z value BESD % improved
MI CG
Blood glucose  5 1.7 [0.82; 1.67] 0.85 52 48
Blood pressure  1 1.65*2 [1.24; 2.19] 3.45 57 43
Cholesterol  3 1.09*1 [1.00; 1.19] 1.92 51 49
Mortality  3 1.87*1 [1.03; 3.40] 2.06 59 41
Caries  2 1.85*2 [1.29; 2.64] 3.36 58 42
Body weight 10 1.17*2 [1.09; 1.27] 4.22 52 48
Alcohol (amount)  9 2.31*2 [1.75; 3.06] 5.86 61 39
Tobacco (abstinence)  8 1.34*1 [1.05; 1.70] 2.38 54 46
Cannabis (amount)  5 3.22*2 [2.14; 2.79] 5.66 65 35
Self-monitoring  4 2.14*2 [1.65; 2.79] 5.67 61 39
Medication adherence  4 1.25 [0.95; 1.65] 1.61 53 47
Treatment adherence  5 1.38*2 [1.18; 1.64] 4.04 55 43
Readiness for change  5 1.97*2 [1.11; 3.48] 2.53 59 41
Quality of life  6 2.21*2 [1.65; 2.96] 5.28 62 38

BESD, binomial effect size display: 2 × 2 table [group (MI, controls) × improvement (yes, no)]; *1p < 0.05; *2p < 0.01 MI, motivational interviewing